What they were paid
Aclaris Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $18,065 | $42,422 | $-1 | $120,486 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aclaris Therapeutics, Inc. DEF 14A filed April 23, 2026, accession 0001104659-26-047262, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Aclaris Therapeutics pays directors a $40,000 cash retainer and $320,000 in Stock Options and RSUs.
Committees
FY2025 · as the proxy prints themAudit (Chair)
The rest of the Aclaris Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Anand Mehra | Independent Director | $120,486 |
| Andrew Schiff | Independent Director | $100,486 |
| Christopher Molineaux | Independent Director | $141,986 |
| Hugh Davis | Director | $0 |
| Maxine Gowen | Independent Director | $107,986 |
| Neal Walker | Chair of the Board | $0 |
| William Humphries | Independent Director | $112,486 |
The full Aclaris Therapeutics compensation record
free company briefThis page is one director within Aclaris Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat